Napredna pretraga

Pregled bibliografske jedinice broj: 708216

Challenges in manufacturing adenoviral vectors for global vaccine product deployment


Vellinga, Jort; Smith, J Patrick; Lipiec, Agnieszka,; Majhen, Dragomira; Lemckert, Angelique; van Ooij, Mark; Ives, Paul; Yallop, Christopher; Custers, Jerome; Havenga, Menzo
Challenges in manufacturing adenoviral vectors for global vaccine product deployment // Human gene therapy, 25 (2014), 318-327 doi:10.1089/hum.2014.007 (međunarodna recenzija, pregledni rad, znanstveni)


Naslov
Challenges in manufacturing adenoviral vectors for global vaccine product deployment

Autori
Vellinga, Jort ; Smith, J Patrick ; Lipiec, Agnieszka, ; Majhen, Dragomira ; Lemckert, Angelique ; van Ooij, Mark ; Ives, Paul ; Yallop, Christopher ; Custers, Jerome ; Havenga, Menzo

Izvornik
Human gene therapy (1043-0342) 25 (2014); 318-327

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
Adenoviral vector manufacturing

Sažetak
Abstract Once adenovirus vector-based vaccines are licensed for the prevention of important infectious diseases, manufacturing processes capable of reliably delivering large numbers of vaccine doses will be required. The highest burden of disease for many infectious pathogens under investigation occurs in resource-poor settings. Therefore, the price per dose will be an important determinant of success. This review describes common practices for manufacturing replication- incompetent adenovirus vectors at clinical scale. Recent innovations and strategies aimed at improving the cost-effectiveness of manufacturing and ensuring high-volume vaccine production and purification are described. Hereto, technologies to increase bioreactor yields are reviewed. In addition, the use of single-use perfusion bioreactors, modification of some purification steps to avoid the use of expensive endonucleases, and use of charged filters during anion exchange all have the potential to bring down the cost of goods and are thus described. Finally, processes for ensuring quality throughout the manufacturing process, methods for testing viral identity, and safety of master seeds through to the end vaccine product are described.

Izvorni jezik
Engleski

Znanstvena područja
Biologija



POVEZANOST RADA


Autor s matičnim brojem:
Dragomira Majhen, (244990)

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati